CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques

Cited by (132)

Items 101–132 of 132

1. CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study
   Isabel Neale, Mohammad Ali, Barbara Kronsteiner, Stéphanie Longet, Priyanka Abraham, Alexandra S. Deeks, Anthony Brown, Shona C. Moore, Lizzie Stafford, Susan L. Dobson et al. · 2023 · medRxiv
2. A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
   Jimin Lee, Cameron Stewart, Alexandra Schaefer, Elizabeth M. Leaf, Young‐Jun Park, Daniel E. Asarnow, John M. Powers, Catherine Treichel, Davide Corti, Ralph Steven Baric et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
3. ChAdOx1 nCoV‐19 vaccination generates spike‐specific CD8+ T cells in aged mice
   William S. Foster, Joseph Newman, Nazia Thakur, Alexandra J. Spencer, Sophie E. Davies, Danielle Woods, Leila Godfrey, Sarah H. Ross, Hayley J. Sharpe, Arianne C. Richard et al. · 2023 · Immunology and Cell Biology
4. Enhancing Immune Responses Through Modulation of Innate Cell Microenvironments in Lymph Nodes with Virus‐Mimetic Vaccines
   Runping Su, Tingting Yao, Chong Cao, Yaqi Yang, Mingshan Chen, Jianxiao Wu, Yue Zhao, Xiaoxiao Liu, Sha Li, Junqiang Ding et al. · 2025 · Angewandte Chemie International Edition
5. Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S
   Mohamed I. M. Ahmed, Michael Plank, Noemi Castelletti, Paulina Diepers, Tabea M. Eser, Raquel Rubio‐Acero, Iván Noreña, Christina Reinkemeyer, Dorinja Zapf, Michael Höelscher et al. · 2023 · Diagnostics
6. Emerging severe acute respiratory syndrome coronavirus 2 variants and their impact on immune evasion and vaccine-induced immunity
   Ramendra Pati Pandey, Sachin A. Kumar, D N Rao, Dablu Lal Gupta · 2024 · Transactions of the Royal Society of Tropical Medicine and Hygiene
7. Early spatiotemporal evolution of the immune response elicited by adenovirus serotype 26 vector vaccination in mice
   Eryn Blass, Alessandro Colarusso, Malika Aïd, Rafael A. Larocca, Roger Keith Reeves, Dan H. Barouch · 2025 · Journal of Virology
8. Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
   Mandolesi, Marco, Das, Hrishikesh, de Vries, Liset, Yang, Yiqiu, Kim, Changil, Dhinakaran, Manojj, Dopico, Xaquin Castro, Fischbach, Julian, Kim, Sungyong, Guryleva, Mariia et al. · 2024
9. Spatiotemporal Dynamic Immunomodulation by Infection‐Mimicking Gels Enhances Broad and Durable Protective Immunity Against Heterologous Viruses
   Seung Mo Jin, Ju Hee Cho, Yebin Seong, W. A. Gayan Chathuranga, Yejin Gwak, Young‐Woock Noh, Min‐Ho Lee, Sang‐Seok Oh, Jin‐Ho Choi, Jong‐Soo Lee et al. · 2025 · Advanced Science
10. Conserved CD8 T cell vaccines without B cell epitopes drive robust protection against SARS-CoV-2 that is enhanced by intranasal boost
    Genghao Chen, Thao Nguyen, Lindsay G. A. McKay, Sravya Sowdamini Nakka, Pan Hu, Julia McBride, Anthony C. T. Liang, Rachel M. Olson, James J. Moon, Andrew David Luster et al. · 2025 · Science Advances
11. Recombinant Bacillus subtilis spores expressing SARS-CoV-2 spike protein induced humoral, mucosal, and cellular immunity in mice
    Atiqah Hazan, Amalia A. Saperi, Nurfatihah Zulkifli, NorAziyah MatRahim, Vunjia Tiong, Hai-Yen Lee, Sazaly AbuBakar · 2025 · Scientific Reports
12. mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
    Charlie Fricke, Lorenz Ulrich, Jana Kochmann, Janina Gergen, Kristina Kovacikova, Nicole Roth, Julius Beer, Daniel Schnepf, Thomas C. Mettenleiter, Susanne Rauch et al. · 2024 · Molecular Therapy — Nucleic Acids
13. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA (BNT162b2/mRNA-1273) and adenovirus vectored vaccines (ChAdOx1-S) after the first, second and third doses
    Feargal J. Ryan, Todd S. Norton, Conor McCafferty, Stephen J. Blake, Natalie E. Stevens, Jane James, Georgina L. Eden, Yee C. Tee, Saoirse C. Benson, Makutiro Ghislain Masavuli et al. · 2022 · medRxiv
14. Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2
    Pritesh Desai, Courtney E. Karl, Baoling Ying, Chieh-Yu Liang, Tamara García‐Salum, Ana Carolina Santana, Felipe ten-Caten, Joseph F. Urban, Sayda M. Elbashir, Darin K. Edwards et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
15. Data from Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
    Maryam I. Azeem, Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee V. Potdar, Renee Julia Manalo, Alberto Moreno, Jeffrey M. Switchenko, Suneethamma Cheedarla, Deon Bryant Doxie et al. · 2023
16. Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination
    Éric Tartour, Nadine Benhamouda, Anissa Besbes, Rebecca Bauer, Nesrine Mabrouk, Gauthier Gadouas, Corinne Desaint, Lucie Chevrier, Maeva Lefebvre, Anne Radenne et al. · 2023 · Research Square
17. Antibody-mediated depletion of select T cell subsets in blood and tissue of nonhuman primates
    Matthew S. Sutton, Allison N. Bucşan, Chelsea C. Lehman, Megha Kamath, Supriya Pokkali, Diogo M. Magnani, Robert A. Seder, Patricia A. Darrah, Mario Roederer · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
18. The 2 nd China Vaccinology Integrated Innovation & Teaching Development Conference: Promoting the construction of vaccinology discipline system
    Yingqi Chen, Yuelong Shu, Hui Zheng, Caijun Sun, Chuanxi Fu · 2024 · Human Vaccines & Immunotherapeutics
19. Development of a new vaccine at the laboratory scale
    Vijay Singh Bohara, Nilave Ranjan Bora, Surajbhan Sevda, Sachin Kumar · 2024 · Elsevier eBooks
20. Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis
    Jenna M. Benoit, Jessica A. Breznik, Angela Huynh, Braeden Cowbrough, Barbara Baker, Lauren Heessels, Sumiya Lodhi, Elizabeth Yan, Hina Bhakta, Rumi Clare et al. · 2024 · Immunology Letters
21. Enhancing Immune Responses Through Modulation of Innate Cell Microenvironments in Lymph Nodes with Virus‐Mimetic Vaccines
    Runping Su, Tingting Yao, Chong Cao, Yaqi Yang, Mingshan Chen, Jianxiao Wu, Yue Zhao, Xiaoxiao Liu, Sha Li, Junqiang Ding et al. · 2025 · Angewandte Chemie
22. Personalized Immune Profiling in Pediatric Transplant Recipients: Linking Atypical B Cells to Vaccine Response
    Johannes Wedel, Ying Tang, Bayan Alsairafi, Vicki Do, Madeline Maslyar, Ryan Fleming, Marc A. Schwartz, Ulrike Gerdemann, Alexandre Albanese, Vanessa Mitsialis et al. · 2025 · medRxiv
23. Comparative single-cell immune responses in peripheral blood and lymph node of immunized SARS-CoV-2 challenged infant rhesus macaques
    S. Anronikov, Cameron Meikle, Emma C. Milligan, Han Chen, Nilanjan Mukherjee, Zach Bjornson, B. Gaudilliere, Si-Zun Jiang, S. Permar, K. V. van Rompay et al. · 2025 · Frontiers in Immunology
24. Effects of aging and inflammation on antigen-specific CD8+ T-cell responses that protect against severe disease following SARS-CoV-2 infection
    Takuto Nogimori, Takuya Yamamoto · 2025 · Uirusu
25. Ganoderma lucidum spore powder enhances IFN-α-mediated antiviral capacity of COVID-19 vaccine boosters revealed by single-cell multi-omics sequencing
    Anyao Li, Xiaoyan Lu, Rongfang Guo, Wenbo Guo, Penghui Yang, He Lou, Jie Chen, Enshan Huang, Ronghua Zhang, Hanbo Wang et al. · 2025 · Journal of Advanced Research
26. Immunogenicity of COVID-19 Vaccines in the Upper Respiratory Tract: A Comparative Study of Pfizer-BioNTech and Johnson & Johnson Vaccines among Ugandan adults
    Victoria Menya Biribawa, Musema Kizito, HenryRoger Ssemunywa, Priscillah Mulungi, Alex Mukisa, Judith Norah Namatovu, Claire Biribawa, Duncan Kabiito, Mudarshiru Bbuye, Henry Kyobe Bosa et al. · 2025
27. Immunogenicity and protective efficacy of MERS CoV, NL140422, and HKU4 spike protein nanoparticle vaccines
    Peter Halfmann, Jeong Soo Lee, Tong Wang, Augustine Duffy, Yoshihiro Kawaoka, Ravi S. Kane · 2026 · npj Viruses
28. Structural Design of T-Cell Epitope-Based mRNA Vaccine Constructs Determines the Quality of T-Cell Immunity and Protective Efficacy Against SARS-CoV-2 in Mice
    Vladimir A. Gushchin, Andrei E. Siniavin, Andrei A. Pochtovyi, Alina Sh. Dzharullaeva, Д. Н. Щербинин, Anastasiya S. Ungur, Тухватулин Амир Ильдарович, Inna V. Shuliakova, Denis A. Kleymenov, Elena P. Mazunina et al. · 2026 · Vaccines
29. Rapid and potent induction of protective mucosal immunity against SARS-CoV-2 by an adenovirus-vectored nanoparticle vaccine
    Shixiong Li, Qiong Zi, Junhao Fan, Guangzhen Jiang, Yao Zhang, Danni Feng, Zumrat Nur, Xiaoqing Liu, Jintao Lai, Tao Chen et al. · 2026 · Journal of Nanobiotechnology
30. Revisiting of the Role of CD8 + T‐Cells in Vaccine‐Induced Protection Against SARS‐CoV‐2 in Macaques via Mathematical Modeling
    Malik Muhammad Ibrahim, Jong Hyuk Byun, Malik Muhammad Naeem Mannan, Kwang Su Kim · 2026 · Complexity
31. Induction of mucosal immune responses against SARS-CoV-2: a heterologous intramuscular mRNA-LNP prime/pulmonary recombinant subunit pull vaccination strategy
    Melike Ongun, Naga Suresh Kola, Dhruv Patel, Tasson C. Rodrigues, S. Schmidt, Abhijeet Girish Lokras, Henrik Franzyk, Søren R. Paludan, Thomas Rades, Aneesh Thakur et al. · 2026 · Scientific Reports
32. Beyond the blood: Tissue-resident immunity shapes SARS-CoV-2 vaccine antibody responses
    Juliane Schröter, Christiaan Hendrik van Dorp, Julia Davis‐Porada, John Ross Teijaro, Donna L. Färber, Andrew J. Yates · 2026 · bioRxiv (Cold Spring Harbor Laboratory)